PTEN and renal carcinoma: In a complementary elegant approach, the group led by Pamela Silver decided to try restoring at least some of the outcomes of PTEN function as a tumour suppressor gene by screening a renal carcinoma cell line (that is deficient in PTEN) for chemicals that relocalise the FOXOla transcription factor to the nucleus (Kau et al, 2003).